Cargando…
Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
Due to high oxygen consumption, the brain is particularly vulnerable to oxidative stress, which is considered an important element in the etiopathogenesis of several mental disorders, including schizophrenia, depression and dependencies. Despite the fact that it is not established yet whether oxidat...
Autores principales: | Ribaudo, Giovanni, Bortoli, Marco, Pavan, Chiara, Zagotto, Giuseppe, Orian, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465375/ https://www.ncbi.nlm.nih.gov/pubmed/32781750 http://dx.doi.org/10.3390/antiox9080714 |
Ejemplares similares
-
Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico
por: Bortoli, Marco, et al.
Publicado: (2019) -
Fluoxetine scaffold to design tandem molecular antioxidants and green catalysts
por: Ribaudo, Giovanni, et al.
Publicado: (2020) -
Antioxidant Chimeric Molecules: Are Chemical Motifs Additive? The Case of a Selenium-Based Ligand
por: Zeppilli, Davide, et al.
Publicado: (2023) -
ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake
por: Ribaudo, Giovanni, et al.
Publicado: (2022) -
Selenoxide Elimination Triggers Enamine Hydrolysis to Primary and Secondary Amines: A Combined Experimental and Theoretical Investigation
por: Ribaudo, Giovanni, et al.
Publicado: (2021)